Compare Piramal Healthcare with Wockhardt - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PIRAMAL ENTERPRISES vs WOCKHARDT - Comparison Results

PIRAMAL ENTERPRISES     Change

Piramal Enterprises has a presence in custom manufacturing, critical care OTC and financial services. To give a boost to its custom manufacturing operations, the company had acquired Avecia Pharmaceuticals, UK in 2005 and Pfizer's Morpeth facility in... More

WOCKHARDT 
   Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PIRAMAL ENTERPRISES WOCKHARDT PIRAMAL ENTERPRISES/
WOCKHARDT
 
P/E (TTM) x -30.7 -50.4 - View Chart
P/BV x 1.0 1.1 92.5% View Chart
Dividend Yield % 2.2 0.0 64,910.3%  

Financials

 PIRAMAL ENTERPRISES   WOCKHARDT
EQUITY SHARE DATA
    PIRAMAL ENTERPRISES
Mar-19
WOCKHARDT
Mar-18
PIRAMAL ENTERPRISES/
WOCKHARDT
5-Yr Chart
Click to enlarge
High Rs3,3031,012 326.3%   
Low Rs1,797532 338.1%   
Sales per share (Unadj.) Rs716.5355.9 201.3%  
Earnings per share (Unadj.) Rs79.7-60.3 -132.2%  
Cash flow per share (Unadj.) Rs107.9-46.8 -230.8%  
Dividends per share (Unadj.) Rs28.000.01 280,000.0%  
Dividend yield (eoy) %1.10 84,751.1%  
Book value per share (Unadj.) Rs1,477.5257.8 573.1%  
Shares outstanding (eoy) m184.45110.63 166.7%   
Bonus/Rights/Conversions IS--  
Price / Sales ratio x3.62.2 164.1%   
Avg P/E ratio x32.0-12.8 -249.9%  
P/CF ratio (eoy) x23.6-16.5 -143.2%  
Price / Book Value ratio x1.73.0 57.6%  
Dividend payout %35.10 -211,757.7%   
Avg Mkt Cap Rs m470,29285,379 550.8%   
No. of employees `0007.86.3 125.0%   
Total wages/salary Rs m22,5049,371 240.2%   
Avg. sales/employee Rs Th16,899.46,295.0 268.5%   
Avg. wages/employee Rs Th2,877.71,498.3 192.1%   
Avg. net profit/employee Rs Th1,879.9-1,066.3 -176.3%   
INCOME DATA
Net Sales Rs m132,15339,369 335.7%  
Other income Rs m3,1281,202 260.2%   
Total revenues Rs m135,28140,571 333.4%   
Gross profit Rs m66,29018 362,238.3%  
Depreciation Rs m5,2021,495 347.9%   
Interest Rs m44,0972,555 1,726.0%   
Profit before tax Rs m20,119-2,830 -711.0%   
Minority Interest Rs m3,1940-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-3,582 0.0%   
Tax Rs m8,611257 3,350.7%   
Profit after tax Rs m14,701-6,669 -220.5%  
Gross profit margin %50.20 107,912.2%  
Effective tax rate %42.8-9.1 -471.3%   
Net profit margin %11.1-16.9 -65.7%  
BALANCE SHEET DATA
Current assets Rs m122,74233,796 363.2%   
Current liabilities Rs m310,81026,917 1,154.7%   
Net working cap to sales %-142.317.5 -814.5%  
Current ratio x0.41.3 31.5%  
Inventory Days Days2379 29.1%  
Debtors Days Days3989 43.5%  
Net fixed assets Rs m116,90439,664 294.7%   
Share capital Rs m369553 66.7%   
"Free" reserves Rs m272,16127,968 973.1%   
Net worth Rs m272,53028,522 955.5%   
Long term debt Rs m270,19621,731 1,243.4%   
Total assets Rs m856,26181,620 1,049.1%  
Interest coverage x1.5-0.1 -1,354.4%   
Debt to equity ratio x1.00.8 130.1%  
Sales to assets ratio x0.20.5 32.0%   
Return on assets %6.9-5.0 -136.3%  
Return on equity %5.4-23.4 -23.1%  
Return on capital %12.4-7.7 -161.8%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m15,2009,807 155.0%   
Fx outflow Rs m4,8891,789 273.3%   
Net fx Rs m10,3128,019 128.6%   
CASH FLOW
From Operations Rs m-115,975684 -16,945.4%  
From Investments Rs m-8,2656,302 -131.1%  
From Financial Activity Rs m107,525-7,695 -1,397.4%  
Net Cashflow Rs m-16,650-664 2,507.6%  

Share Holding

Indian Promoters % 52.9 74.5 71.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.0 2.3 173.9%  
FIIs % 26.6 7.7 345.5%  
ADR/GDR % 0.0 0.1 -  
Free float % 16.5 15.4 107.1%  
Shareholders   93,274 67,757 137.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PIRAMAL ENTERPRISES With:   SUN PHARMA  ORCHID PHARMA  NOVARTIS  FULFORD INDIA  PROCTER & GAMBLE HEALTH  

Compare PIRAMAL ENTERPRISES With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens Lower Tracking Weak Global Cues; L&T Slips 4% Post Q2 Results(09:30 am)

Asian share markets are trading on a negative note today. The Nikkei is trading down by 0.7% and the Hang Seng is trading lower by 1%.

Related Views on News

PIRAMAL ENTERPRISES Announces Quarterly Results (1QFY21); Net Profit Up 22.1% (Quarterly Result Update)

Aug 25, 2020 | Updated on Aug 25, 2020

For the quarter ended June 2020, PIRAMAL ENTERPRISES has posted a net profit of Rs 5 bn (up 22.1% YoY). Sales on the other hand came in at Rs 29 bn (down 16.2% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

PIRAMAL ENTERPRISES Announces Quarterly Results (3QFY20); Net Profit Up 11.7% (Quarterly Result Update)

Feb 5, 2020 | Updated on Feb 5, 2020

For the quarter ended December 2019, PIRAMAL ENTERPRISES has posted a net profit of Rs 6 bn (up 11.7% YoY). Sales on the other hand came in at Rs 38 bn (up 9.1% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

WOCKHARDT Announces Quarterly Results (3QFY20); Net Profit Up 125.0% (Quarterly Result Update)

Jan 28, 2020 | Updated on Jan 28, 2020

For the quarter ended December 2019, WOCKHARDT has posted a net profit of Rs 192 m (up 125.0% YoY). Sales on the other hand came in at Rs 9 bn (down 16.9% YoY). Read on for a complete analysis of WOCKHARDT's quarterly results.

PIRAMAL ENTERPRISES Announces Quarterly Results (2QFY20); Net Profit Up 16.5% (Quarterly Result Update)

Oct 25, 2019 | Updated on Oct 25, 2019

For the quarter ended September 2019, PIRAMAL ENTERPRISES has posted a net profit of Rs 6 bn (up 16.5% YoY). Sales on the other hand came in at Rs 36 bn (up 14.6% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

WOCKHARDT Announces Quarterly Results (1QFY20); Net Profit Up 57.2% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, WOCKHARDT has posted a net profit of Rs 369 m (up 57.2% YoY). Sales on the other hand came in at Rs 9 bn (down 14.3% YoY). Read on for a complete analysis of WOCKHARDT's quarterly results.

More Views on News

Most Popular

My View on ITC(Fast Profits Daily)

Oct 23, 2020

What do the charts say about ITC?

PSU Banks Will Move Up Again(Profit Hunter)

Oct 27, 2020

My charts tell me PSU banks are set for a rebound.

One of the Best Investment Opportunities in the Market Right Now(Fast Profits Daily)

Oct 16, 2020

The one sector that you should be looking at to make good profits.

Why India's Drone Revolution is a 4x Profit Opportunity(Profit Hunter)

Oct 16, 2020

My research on India's leading defence companies brought me to one major player in drone manufacturing.

More

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

PIRAMAL ENTERPRISES SHARE PRICE


Oct 29, 2020 10:38 AM

TRACK PIRAMAL ENTERPRISES

  • Track your investment in PIRAMAL ENTERPRISES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PIRAMAL ENTERPRISES

PIRAMAL ENTERPRISES - GLENMARK PHARMA COMPARISON

COMPARE PIRAMAL ENTERPRISES WITH

MARKET STATS